Organic−inorganic hybrid nonlinear optical (NLO) crystals have been attracting increasing attention because of their unique ability to combine the structural diversity of the organic moiety and the high stability of the inorganic moiety. However, organic NLO genes are rare. Herein, a new organic NLO material gene, the 2aminopyrimidinium cation (C 4 H 6 N 3 ) + ((2AP) + ), is reported, which constructs a novel organic−inorganic hybrid (C 4 H 6 N 3 ) + (H 2 PO 3 ) − (2APP) that exhibits excellent NLO properties and thermal stability, e.g., strong second-harmonic generation (SHG) intensity (2 × KDP), large birefringence (0.225 at 589.3 nm), high laser-induced-damage threshold (1.7 × KDP), and one of the highest thermal stabilities among the metal-free-(2AP) + -containing compounds. Our first-principles theoretical studies confirm the dominant contribution of (2AP) + to optical properties. The inorganic phosphite anions well separate the (2AP) + cations to successfully eliminate the unwanted centrosymmetric trap that is induced by the dipole−dipole interactions between (2AP) + cations. Furthermore, the unique layered structure decorated by the uniformly oriented individual (2AP) + chromophores, dramatically enhances the quantum yield of purple fluorescence (Φ = 30.6%), which is 3 orders of magnitude higher than that of pure 2AP and its derivatives.
The first alkaline‐earth metal tin(II) phosphate, BaSn2(PO4)2, has been discovered, which consists of layered structures constructed from strictly alternating [SnO3]4− and [PO4]3− moieties. This compound is expected to have a large birefringence with Δn≈0.071 at 1064 nm, owing to the presence of stereochemically active lone pair metal cations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.